The Medicaid and CHIP Payment and Access Commission approved recommendations it will issue to Congress in its June report on oversight and increased transparency of artificial intelligence usage for prior authorization. The commission recommended that the Centers for Medicare & Medicaid Services clarify federal requirements that, for determinations of medical necessity, all adverse determinations, such as denials or reductions in requested services, must be reviewed and authorized by an individual with appropriate expertise and may not be made by automation tools alone. It also recommended CMS amend fee-for-service regulations to establish similar requirements and issue guidance on oversight of managed care use of automation, and that states require Medicaid health plans to disclose their use of automation, including testing, evaluation and oversight. 

Headline
The AHA Aug. 13 responded to a Food and Drug Administration request for input on the risks and benefits to health and safety associated with non-device…
Headline
The Common Health Coalition announced Aug. 13 that it will receive $100 million in funding from the OpenAI Foundation for a new initiative using artificial…
Headline
The AHA July 31 provided comments to the Centers for Medicare & Medicaid Services on its interim final rule on Medicaid community engagement requirements.…
Headline
The AHA’s American Organization for Nursing Leadership will host a webinar Aug. 5 at noon ET on how nurse leaders can guide ambient documentation from pilot…
Headline
In this conversation, Ajay Gupta, board vice chair for Trinity Health Mid-Atlantic, explains how trustees can confidently guide artificial intelligence…
Headline
An AHA blog published July 28 highlights new electronic prior authorization requirements that begin Jan. 1, 2027, as a result of the Centers for Medicare…